Dianthus Therapeutics, Inc. · GETTEX:87E

Dianthus Therapeutics, Inc. insider trades

Dianthus Therapeutics, Inc.'s insiders made 0 buys and 58 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

InsiderTradeSharesPriceValueDate
Savitz Ryan
Officer: EVP, CFO & CBO
Sale17,724USD 90.56US$1.61MNov 12, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale3,044USD 90.03US$274KNov 11, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale2,561USD 90.14US$231KNov 10, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale2,064USD 91.59US$189KNov 9, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale300USD 85.16US$25,548Nov 9, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale700USD 86.70US$60,690Nov 9, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale1,736USD 88.84US$154KNov 9, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale37,517USD 90.12US$3.38MNov 9, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale58,396USD 90.90US$5.31MNov 9, 2026
Carr Edward
Officer: CHIEF ACCOUNTING OFFICER
Sale7,928USD 100.43US$796KSep 17, 2026
Carr Edward
Officer: CHIEF ACCOUNTING OFFICER
Sale6,771USD 101.37US$686KSep 17, 2026
Carr Edward
Officer: CHIEF ACCOUNTING OFFICER
Sale3,501USD 102.39US$358KSep 17, 2026
Carr Edward
Officer: CHIEF ACCOUNTING OFFICER
Sale1,100USD 103.20US$114KSep 17, 2026
Carr Edward
Officer: CHIEF ACCOUNTING OFFICER
Sale700USD 104.39US$73,073Sep 17, 2026
Randhawa Simrat
Officer: EVP, Head of R&D
Sale2,600USD 105.19US$273KSep 1, 2026
Randhawa Simrat
Officer: EVP, Head of R&D
Sale7,215USD 106.25US$767KSep 1, 2026
Randhawa Simrat
Officer: EVP, Head of R&D
Sale13,309USD 106.74US$1.42MSep 1, 2026
Read Simon
Director
Sale2,778USD 117.55US$327KAug 19, 2026
Read Simon
Director
Sale70USD 107.11US$7,498Aug 10, 2026
Read Simon
Director
Sale737USD 108.17US$79,721Aug 10, 2026
Read Simon
Director
Sale831USD 108.95US$90,537Aug 10, 2026
Read Simon
Director
Sale272USD 109.96US$29,909Aug 10, 2026
Read Simon
Director
Sale470USD 111.05US$52,194Aug 10, 2026
Read Simon
Director
Sale397USD 111.77US$44,373Aug 10, 2026
Veness Adam M
Officer: SVP, General Counsel and Sec.
Sale16,167USD 110.38US$1.78MAug 10, 2026
McGeorge Anne
Director
Sale1,450USD 107.58US$156KAug 10, 2026
McGeorge Anne
Director
Sale2,800USD 108.38US$303KAug 10, 2026
McGeorge Anne
Director
Sale1,800USD 109.30US$197KAug 10, 2026
McGeorge Anne
Director
Sale1,000USD 110.64US$111KAug 10, 2026
McGeorge Anne
Director
Sale700USD 111.41US$77,987Aug 10, 2026
Veness Adam M
Officer: SVP, General Counsel and Sec.
Sale3,217USD 110.61US$356KAug 7, 2026
Veness Adam M
Officer: SVP, General Counsel and Sec.
Sale616USD 111.18US$68,487Aug 7, 2026
Garcia Marino
Director, Officer: CEO AND PRESIDENT
Sale10,384USD 107.49US$1.12MAug 7, 2026
Garcia Marino
Director, Officer: CEO AND PRESIDENT
Sale23,907USD 108.05US$2.58MAug 7, 2026
Garcia Marino
Director, Officer: CEO AND PRESIDENT
Sale2,373USD 109.10US$259KAug 7, 2026
Garcia Marino
Director, Officer: CEO AND PRESIDENT
Sale2,536USD 110.02US$279KAug 7, 2026
Garcia Marino
Director, Officer: CEO AND PRESIDENT
Sale800USD 110.76US$88,608Aug 7, 2026
Garcia Marino
Director, Officer: CEO AND PRESIDENT
Sale104,091USD 107.96US$11.2MAug 7, 2026
Garcia Marino
Director, Officer: CEO AND PRESIDENT
Sale21,909USD 108.72US$2.38MAug 7, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale10,354USD 100.22US$1.04MJul 9, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale15,329USD 101.24US$1.55MJul 9, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale5,566USD 101.97US$568KJul 9, 2026
Veness Adam M
Officer: SVP, General Counsel and Sec.
Sale16,771USD 80.34US$1.35MJun 17, 2026
Veness Adam M
Officer: SVP, General Counsel and Sec.
Sale13,229USD 81.38US$1.08MJun 17, 2026
Randhawa Simrat
Officer: EVP, Head of R&D
Sale5,428USD 89.72US$487KJun 1, 2026
Randhawa Simrat
Officer: EVP, Head of R&D
Sale16,943USD 90.72US$1.54MJun 1, 2026
Randhawa Simrat
Officer: EVP, Head of R&D
Sale4,159USD 91.37US$380KJun 1, 2026
Soteropoulos Paula
Director
Sale599USD 85.47US$51,197May 8, 2026
Savitz Ryan
Officer: EVP, CFO & CBO
Sale8,224USD 89.84US$739KApr 9, 2026
Soteropoulos Paula
Director
Sale599USD 80.11US$47,986Mar 31, 2026

This page holds 50 of 58 trades.

Dianthus Therapeutics, Inc. shareholders